10 citations
,
October 1992 in “Hormone and Metabolic Research” Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.
9 citations
,
January 2020 Using poppers can cause vision problems, but stopping their use might lead to complete recovery over time.
8 citations
,
April 2004 in “The Journal of Urology” Doxazosin and finasteride negatively affect sexual function in men with BPH.
7 citations
,
May 2002 in “Hair transplant forum international” Finasteride 1mg is effective and safe for long-term use in treating male hair loss.
5 citations
,
September 2015 in “PLoS ONE” Gelfoam® histoculture supports long-term hair and nerve growth in mouse whisker follicles.
5 citations
,
October 1988 in “Diabetes Research and Clinical Practice” Hair glycation can indicate long-term blood sugar trends in diabetics.
4 citations
,
November 2023 in “PLoS ONE” Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.
2 citations
,
September 2022 in “Dermatologic Therapy” Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.
1 citations
,
September 2025 in “Viruses” Hantavirus survivors often face long-term health issues, needing ongoing care.
1 citations
,
June 2025 in “Supportive Care in Cancer” Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.
1 citations
,
April 2024 in “Journal of Clinical Nursing” COVID-19 has caused lasting physical and mental health issues for surgical nurses.
1 citations
,
October 2023 in “European Journal of Dermatology” Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.
1 citations
,
January 1997 in “Journal of Investigative Dermatology” RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Effective hair restoration requires long-term planning, scalp health, and a mix of treatments.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Effective hair restoration requires long-term planning, scalp health, and a combination of treatments for sustainable results.
December 2025 in “Asthma Allergy Immunology” Hematopoietic stem cell transplantation does not significantly affect COVID-19 severity in children with immune disorders.
July 2025 in “Journal of the European Academy of Dermatology and Venereology” April 2025 in “Journal of Cosmetic Dermatology” Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.
March 2025 in “SKIN The Journal of Cutaneous Medicine”
January 2025 in “SKIN The Journal of Cutaneous Medicine” Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.
January 2025 in “Journal of Materials Chemistry B” The new microneedle treatment could be a more effective and convenient option for hair loss.
November 2024 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.
May 2024 in “Journal of the Egyptian Womenʼs Dermatologic Society” Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.
August 2023 in “Research Square (Research Square)” Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.
May 2023 in “British Journal of Dermatology” COVID-19 can cause long-term skin problems and has changed how skin doctors work.
October 2022 in “bioRxiv (Cold Spring Harbor Laboratory)” Small changes in cell division and differentiation can activate blood progenitors.
COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.
December 2020 in “Journal of Pakistan Association of Dermatology” COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
February 2018 in “Dermatologic Surgery”
May 2015 in “Journal of The American Academy of Dermatology” Combination therapy with cyclosporine and low-dose corticosteroid shows favorable long-term results for treating alopecia areata.